Our approach

AI-powered drug discovery

We built K Pro, an AI scientist powered by multimodal patient data and advanced AI skills to drive smarter drug discovery for biopharma.
Learn more
Owkin OrbDrug Discovery LaboratoryScientist

What we do

We combine powerful biological LLMs, multimodal patient data and over a decade of biomedical AI tools and expertise into a single AI Scientist, K Pro.

Context

Drug discovery is becoming slower and more expensive over time

$2.7Bn

Median cost of bringing an oncology or immunology drug to market

>13yrs

Time to bring a drug to market

90%

High attrition rate results in only 10% of drugs reaching the market

Challenges

We need better drugs, better targets, and better clinical trials

Challenge 1

Targets don’t convert to drugs

  • Patient data is underutilized
  • Pre-clinical models lack translatability to human biology
  • Disease heterogeneity is not captured

Challenge 2

Drug responses vary between patients

  • Lack understanding of tumor microenvironment
  • Lack understanding of drug mechanism of action
  • Incomplete knowledge of clinical heterogeneity
Example Use Cases

Discover how K Pro powers smarter pipeline decisions

K Pro's flexible architecture means it can tackle your specific challenges, even ones we haven't anticipated yet.
Early Portfolio Decisions
Early Portfolio Decisions

Assess drug/program opportunities with confidence.

Patient & Population Decisions
Patient & Population Decisions

Define the right patient populations and predictive biomarkers before your trial starts.

Clinical Trial Decisions
Clinical Trial Decisions

Enrich early clinical trial data with real-world insights.

Ready to get started?
Get in touch for a Demo

Discover how K Pro can transform your drug discovery and development. Connect with our team to explore how we can support your specific needs.

Book a Demo
K Pro FAQs
Questions?

Search for answers to our most commonly asked questions about K Pro.

Search FAQs
Button